OnKure Therapeutics, Inc. Class A (OKUR) Dividend History

OnKure Therapeutics, Inc. Class A (OKUR) is a biopharmaceutical company focused on developing innovative cancer therapies. It specializes in creating targeted treatments aimed at improving outcomes for patients with various malignancies, utilizing cutting-edge research and technology to address unmet medical needs in oncology.

18575 Jamboree Road, Irvine, CA, 92612
Phone: (858) 283-0280
Website: https://www.onkuretherapeutics.com

Dividend History

OnKure Therapeutics, Inc. Class A currently does not pay dividends

Company News

OnKure Announces Encouraging Preliminary Safety, Tolerability, and Pharmacokinetic (PK) Data from its First-In-Human PIKture-01 Trial of OKI-219

OnKure Therapeutics announced positive preliminary data from its first-in-human trial of OKI-219, a PI3Kα inhibitor, showing good tolerability and favorable pharmacokinetics. The company plans to initiate a combination trial with fulvestrant in the second half of 2025.

GlobeNewswire Inc.

Page data last updated 08/19/2025 17:04:08 UTC